EOM Pharmaceuticals Holdings
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$1,612,737 over the previous period. Total operating expenses were $1,816,320.

Profit Margin

EOM Pharmaceuticals Holdings, Inc. (OTC:IMUC): Profit margin
2012 0 -14.5M
2013 0 -8.75M
2014 0 -9.39M
2015 0 -12.92M
2016 0 -23.39M
2017 0 -18.51M
2020 0 -1.45M
2021 0 -5.14M
2022 0 -2.64M
2023 0 -1.61M

IMUC Income Statement (2012 – 2023)

2023 2022 2021 2020 2017 2016 2015 2014 2013 2012
Revenue
Revenue
0000000000
Cost of revenue
000047.76K036.19K47.65K00
Gross profit
0000-47.76K0-36.19K-47.65K00
Operating exp.
Research and development
580.91K1.22M1.30M696.71K17.12M19.10M10.89M5.96M5.33M7.71M
Selling and marketing
00554632K000000
Total operating expenses
1.81M2.88M2.61M1.45M21.15M24.11M15.51M9.85M9.46M11.82M
Operating income
-1.81M-2.88M-2.61M-1.45M-21.15M-24.11M-15.51M-9.85M-9.46M-11.82M
Other income (expenses), net
203.58K238.40K-2.53M06.84M2.02M2.72M481.00K659.75K-2.67M
Income before tax
-1.61M-2.64M-5.14M-1.45M-14.31M-22.08M-12.79M-9.37M-8.80M-14.5M
Income tax expense
-167.89K0-2.61K-1.93K4.20M1.31M133.90K15.02K-50.40K0
Net income
-1.61M-2.64M-5.14M-1.45M-18.51M-23.39M-12.92M-9.39M-8.75M-14.5M
Earnings per share
Basic EPS
-0.01-0.02-0.04-0.03-4.42-83.6-59.29-64.1-64.48-112.58
Diluted EPS
-0.01-0.02-0.04-0.03-4.42-83.6-59.29-64.1-64.48-112.58
Data sourceData sourceData sourceData sourceData sourceData source